Broad Spectrum Antivirals: Part I
Spectrum Analysis
Broad spectrum antivirals shift the drug model paradigm
by Jeannie Wraight
The recent spread of emerging pandemic viruses such as Zika and Ebola has increased...
Toxoplasmosis & HIV
A new study published in the Journal of Immunology suggests that co-infection with toxoplasmosis (toxo), a parasitic infection common in people with AIDS, may...
Interferon & HIV
Luis J. Montaner DVM, D.Phil, of the Wistar Institute in Philadelphia, Pennsylvania has been studying the effects of interferon on HIV DNA and its...
Orphaned Vaccines
Sometimes viewing a complex issue in its most simplistic form can help us to understand where a problem lies. HIV is a virus that...
Collaborative Research: An Interview with Linos Vandekerckhove, MD
Collaborative Research
Linos Vandekerckhove, MD, Enlists Patients to Help Codesign Protocols
by Jeannie Wraight
Ihad the opportunity to speak with Linos Vandekerckhove, MD, of the HIV Cure...
RIVER Study: Kick & Kill Vaccine Strategy
RIVER Dry
Kick and kill strategy study yields disappointing results
by Jeannie Wraight
Latent HIV resides in cells in blood and tissue which we collectively call the...
Trump Strives to End HIV, But at Whose Expense?
A Plan for America
The Trump administration strives to end the HIV epidemic, but at whose expense?
by Jeannie Wraight
In this month’s Destination: Cure I’m going...
Post-Treatment Controllers & HIV Treatment
Control Issues
What can post-treatment controllers tell us about HIV care and treatment?
by Jeannie Wraight
In order to keep their virus suppressed, most people living with...
ABX 464 Aims to Reduce HIV Reservoirs
Revving Up
Investigational agent ABX 464 seeks to reduce HIV reservoirs
by Jeannie Wraight
ABX 464 is making its way through clinical trials, showing strong potential as...
Cure News
News of the Day
The latest reports on HIV cure research show momentum
by Jeannie Wraight
Here’s a look at some of the HIV cure headlines over...